** Shares of health insurer Humana HUM.N rise 5% to $244.5 premarket
** Co forecasts 2025 adj EPS to be ~$17 vs its previous estimate of ~$16.25
** Insurers have been grappling with persistently high costs due to increased use of healthcare services across government-backed health plans
** HUM reports Q2 medical cost ratio - the percentage of premiums spent on medical care - of 89.7% in line with analysts' estimates of 89.71%, according to data compiled by LSEG
** HUM posts Q2 adj EPS of $6.27, above analysts' estimate of $5.92
** Up to last close, stock down over 8% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。